» Articles » PMID: 25317191

Synthesis and Evaluation of the Anxiolytic Activity of Some Phthalimide Derivatives in Mice Model of Anxiety

Overview
Publisher Brieflands
Specialty Pharmacology
Date 2014 Oct 16
PMID 25317191
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to synthesis a series of phthalimides based on our previous works and examine their anxiolytic properties. Using a three steps process, phthalimides were prepared from the corresponding di-methyl phthalate derivatives. Phthalic anhydride was nitrated to produce 3-nitrophthalic acid. Ring closer of either 3-nitrophthalic acid or di-methyl phthalate with urea were carried out in reflux condition. Final compounds were prepared by base catalyzed condensation of 4-methylbenzoyl chloride, benzoyl chloride and benzyl chloride with the resulting imides. From the tested compounds, only N-benzoyl 3-nitro-phthalimide was shown to produce anxiolytic activity by increasing the number of entries and time spent in open arms at 10 mg/kg.

Citing Articles

Phthalimides: developments in synthesis and functionalization.

Doraghi F, Morshedsolouk M, Zahedi N, Larijani B, Mahdavi M RSC Adv. 2024; 14(32):22809-22827.

PMID: 39035712 PMC: 11259108. DOI: 10.1039/d4ra03859b.


Phthalic anhydride (PA): a valuable substrate in organic transformations.

Nikoofar K, Sadathosainy M RSC Adv. 2023; 13(34):23870-23946.

PMID: 37588043 PMC: 10426397. DOI: 10.1039/d3ra03378c.


Structure-activity relationships of sulfonamides derived from carvacrol and their potential for the treatment of Alzheimer's disease.

de Souza M, Andreolla M, Ribeiro T, Goncalves A, Medeiros A, de Souza A RSC Med Chem. 2021; 11(2):307-316.

PMID: 33479638 PMC: 7429979. DOI: 10.1039/d0md00009d.


Amide Synthesis through the In Situ Generation of Chloro- and Imido-Phosphonium Salts.

Irving C, Floreancig J, Laulhe S ACS Omega. 2020; 5(25):15734-15745.

PMID: 32637849 PMC: 7331200. DOI: 10.1021/acsomega.0c02309.


Design and Synthesis of 4-flurophthalimides as potential anticonvulsant agents.

Iman M, Fakhari S, Jahanpanah M, Naderi N, Davood A Iran J Pharm Res. 2018; 17(3):896-905.

PMID: 30127813 PMC: 6094442.


References
1.
Lister R . The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl). 1987; 92(2):180-5. DOI: 10.1007/BF00177912. View

2.
Nicholson A, Pascoe P . Hypnotic activity of an imidazo-pyridine (zolpidem). Br J Clin Pharmacol. 1986; 21(2):205-11. PMC: 1400921. DOI: 10.1111/j.1365-2125.1986.tb05176.x. View

3.
Rodgers R, Cao B, Dalvi A, Holmes A . Animal models of anxiety: an ethological perspective. Braz J Med Biol Res. 1997; 30(3):289-304. DOI: 10.1590/s0100-879x1997000300002. View

4.
Dawson G, Tricklebank M . Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci. 1995; 16(2):33-6. DOI: 10.1016/s0165-6147(00)88973-7. View

5.
Hogg S . A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav. 1996; 54(1):21-30. DOI: 10.1016/0091-3057(95)02126-4. View